• Home
  • About Us
  • Calendar
  • Facebook
  • Twitter

Sleep Scholar

Sleep Scholar for Sleep Medicine Professionals

  • Calendar
  • About Us
You are here: Home / Uncategorized / Five years of sleep apnea treatment with a mandibular advancement device. Side effects and technical complications

Five years of sleep apnea treatment with a mandibular advancement device. Side effects and technical complications

July 23, 2011 by Randy Clare Leave a Comment
Martínez-Gomis J, Willaert E, Nogues L, Pascual M, Somoza M, Monasterio C.

Source

Department of Prosthodontics, Faculty of Dentistry, University of Barcelona, Campus de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain. jmartinezgomis@ub.edu

Abstract

OBJECTIVE:

To determine the variation in prevalence of temporomandibular disorders (TMD), other side effects, and technical complications during 5 years of sleep apnea treatment with a mandibular advancement device.

MATERIALS AND METHODS:

Forty patients diagnosed with obstructive sleep apnea received an adjustable appliance at 70% of the maximum protrusion. The protrusion was then progressively increased. TMD (diagnosed according to the Research Diagnostic Criteria for TMD), overjet, overbite, occlusal contacts, subjective side effects, and technical complications were recorded before and a mean of 14, 21, and 58 months after treatment and analyzed by the Wilcoxon test (P < .05).

RESULTS:

Fifteen patients still used the oral appliance at the 5-year follow-up, and no significant variation in TMD prevalence was observed. Subjective side effects were common, and a significant reduction was found in overjet, overbite, and in the number of occlusal contacts. Furthermore, the patients made a mean of 2.5 unscheduled dental visits per year and a mean of 0.8 appliance repairs/relines per year by a dental technician. The most frequent unscheduled visits were needed during the first year and were a result of acrylic breakage on the lateral telescopic attachment, poor retention, and other adjustments to improve comfort.

CONCLUSIONS:

Five-year oral appliance treatment does not affect TMD prevalence but is associated with permanent occlusal changes in most sleep apnea patients during the first 2 years. Patients seek several unscheduled visits, mainly because of technical complications.

Angle Orthod. 2010 Jan;80(1):30-6

Related posts:

  1. Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance – a three-year follow-up
  2. Compliance and Side Effects in Sleep Apnea Patients Treated With Nasal Continuous Positive Airway Pressure
  3. Effects of Mandibular Posture on Obstructive Sleep Apnea Severity and the Temporomandibular Joint in Patients Fitted with an Oral Appliance
  4. Analysis of the influence of a mandibular advancement device on sleep and sleep bruxism scores by means of the BiteStrip and the Sleep Assessment Questionnaire
  5. Predictors of Response to a Nasal Expiratory Resistor Device and Its Potential Mechanisms of Action for Treatment of Obstructive Sleep Apnea
Filed Under: Uncategorized

Speak Your Mind Cancel reply

*

*


two + = 5

Search

Editorial Board

Randy Clare
Managing Editor of SleepScholar and RespiratoryScholar
Dr. Steve Carstensen
Pankey Institute for Advanced Dental Education, American Academy of Dental Sleep Medicine.
Ruchir Patel MD
Founder & Medical Director at the Insomnia and Sleep Institute of Arizona.
Dr. John S. Viviano
AADSM Diplomate and member of various sleep organizations. Has lectured internationally on the treatment of Sleep-Disordered Breathing and the use of Acoustic Reflection.
Jeffroy Wyscarver
President, DDME Online, Sleep Lab Technology and Services for the Dental Community.
Claude Albertario
RPSGT, speaker, author and mentor in the field of sleep diagnostics with 25 yrs of management experience in one of New York's premier sleep centers.
Joseph Anderson
Co-Founder and Director of Education for Priority Health Education and Priority Scoring.
Todd Austin
Managed sleep labs and has 15 experience in sleep diagnostics and therapeutic systems. .
Marietta Bibbs
Sleep specialist and manager of Sleep and Neurodiagnostics at Morton Plant Mease Healthcare.
Bradley Eli DMD, MS
Director, San Diego Headache and Facial Pain Center / Sleep Treatment and Research Institute
Edward Grandi
Executive Director of the American Sleep Apnea Association.
Edward Michaelson MD
Board Certified in Pulmonary Medicine, Internal Medicine and Sleep Medicine
Ashley Truitt
Founder & Director of Dental Sleep Medicine Worldwide, Co-Founder of TPT Dental.

Upcoming Events

Georgia Association of Sleep Professionals
April 30, Atlanta, GA

No related posts.

Category: Uncategorized

Archives

  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • September 2010
  • August 2010

Random Posts

Scottsdale Study Club September and October Dates

Jazz Pharma Earnings Increase due to Growth of Narcolepsy Drug Xyrem

Use of Flow–Volume Curves to Predict Oral Appliance Treatment Outcome in Obstructive Sleep Apnea

AADSM 2011 Annual Meeting June 10-12

AASM shifts sleep strategy

Return to top of page

Copyright © 2013 Sleep Scholar